EUVIMEDEUVIMED entdecken
Crossref

Iteratively Designed Phospholipid-Targeted Supramolecular Sonosensitizers for Precision Treatment of Pulmonary Infections

Qian Li, Yida Pang, Junhua Zhang, Yanping Liu, Hui Chen, Yuting Wang, Longcan Mei, Le Tu, Junrong Li iD, Yao Sun iD

Journal of the American Chemical Society · 02.09.2026 · 148 (34) · 36969-36982

DOI: 10.1021/jacs.6c10086 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Chemical Society, online erschienen am 18.08.2026. Verfasst von Qian Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemistry, Central China Normal University, Wuhan430079, China. Hauptthemen laut MEDLINE: Phospholipids, Antifungal Agents, Candidiasis, Drug Design. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 79 Literaturangaben. Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation, Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fungal infections represent a significant global health threat, exacerbated by the scarcity of new therapeutic options, increasing drug resistance, and host toxicity. Sonodynamic therapy (SDT) offers a promising approach to overcoming antimicrobial resistance by enabling the localized generation of cytotoxic reactive oxygen species (ROS) within deep-seated lesions. Nevertheless, reports of SDT for in vivo antifungal treatment remain scarce, largely due to suboptimal ROS generation efficiency, poor biofilm penetration, and a lack of fungal specificity. Herein, we report the iterative design of RuB-C12, a phospholipid-targeted supramolecular sonosensitizer assembled via molecular engineering of ligand and acceptor building blocks into a Ru(II) metallocycle. Upon ultrasound activation, RuB-C12 markedly enhances ROS production while simultaneously improving the fungal membrane affinity and biofilm penetration. Mechanistic studies reveal that RuB-C12 effectively eradicates pathogenic yeasts by disrupting phospholipid phase transitions and perturbing intracellular redox homeostasis. Notably, RuB-C12 demonstrates a superior selectivity index (SI = 10–20) toward mammalian cells compared with the clinically approved amphotericin B (SI < 5). In murine models of wound and pulmonary Candida albicans infections as well as in clinical specimens, RuB-C12-mediated SDT significantly reduces fungal burden without inducing observable systemic toxicity. Collectively, this work highlights host–pathogen lipid disparity as a promising paradigm for developing precision antifungal strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhospholipidsAntifungal AgentsCandidiasisDrug DesignUltrasonic TherapyAnimalsMiceReactive Oxygen SpeciesCandida albicansHumansRutheniumMicrobial Sensitivity Tests

Substanzen

PhospholipidsAntifungal AgentsReactive Oxygen SpeciesRuthenium

Autor:innen und Institutionen

  • College of Chemistry, Central China Normal University, Wuhan430079, China.
  • National Key Laboratory of Agricultural Microbiology, College of Biomedicine and Health, Huazhong Agricultural University, Wuhan430070, China.
  • Department of Neurology, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan430071, China.
  • Department of Dermatology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan430030, China.
  • Hubei Jiangxia Laboratory, Wuhan430020, China.

ORCID-Profile: Junrong Li, Yao Sun

Förderung

  • National Natural Science Foundation of China
  • China Postdoctoral Science Foundation
  • Fundamental Research Funds for the Central Universities
  • State Key Laboratory of Green Pesticide

Zitieren

APA

Li, Q., Pang, Y., Zhang, J., Liu, Y., Chen, H., Wang, Y., Mei, L., Tu, L., Li, J., & Sun, Y. (2026). Iteratively Designed Phospholipid-Targeted Supramolecular Sonosensitizers for Precision Treatment of Pulmonary Infections. Journal of the American Chemical Society, 148(34), 36969-36982. https://doi.org/10.1021/jacs.6c10086

Vancouver

Li Q, Pang Y, Zhang J, Liu Y, Chen H, Wang Y, et al. Iteratively Designed Phospholipid-Targeted Supramolecular Sonosensitizers for Precision Treatment of Pulmonary Infections. Journal of the American Chemical Society. 2026;148(34):36969-36982. doi:10.1021/jacs.6c10086

BibTeX
@article{Li2026,
  author = {Li, Qian and Pang, Yida and Zhang, Junhua and Liu, Yanping and Chen, Hui and Wang, Yuting and Mei, Longcan and Tu, Le and Li, Junrong and Sun, Yao},
  title = {Iteratively Designed Phospholipid-Targeted Supramolecular Sonosensitizers for Precision Treatment of Pulmonary Infections},
  journal = {Journal of the American Chemical Society},
  year = {2026},
  volume = {148},
  number = {34},
  pages = {36969--36982},
  doi = {10.1021/jacs.6c10086}
}
Kostenlos starten →